Suppression of tumor driver α-Enolase in endometrial cancer cells significantly reduced proliferation and invasion in vitro, as well as tumorigenicity in vivo, by the inactivation of PI3K/AKT signaling. The gene discussed is AKT1; the disease is endometrial cancer.